Jasper Therapeutics announces special shareholder meeting
JSPR•Special stockholder meeting scheduled for Sept. 30, 2026
Jasper Therapeutics will hold a virtual special stockholder meeting on Sept. 30, 2026.
Meeting adjournment may be used to seek additional support
The agenda also includes a possible meeting adjournment to seek additional support for the reverse split or share authorization increase.
Shareholders to vote on reverse split and share authorization increase
Shareholders will vote on a potential reverse stock split, with the board authorized to set a ratio from 1-for-15 to 1-for-35.
A separate proposal seeks to raise authorized common shares to 675,000,000 from 490,000,000.
